MIRM - Mirum Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MIRM is currently covered by 9 analysts with an average price target of $81.15. This is a potential upside of $21.33 (35.66%) from yesterday's end of day stock price of $59.82.

Mirum Pharmaceuticals's activity chart (see below) currently has 86 price targets and 119 ratings on display. The stock rating distribution of MIRM is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.64% with an average time for these price targets to be met of 577.75 days.

Highest price target for MIRM is $82, Lowest price target is $49, average price target is $62.56.

Most recent stock forecast was given by STEVEN SEEDHOUSE from RAYMOND JAMES on 07-Aug-2025. First documented stock forecast 12-Aug-2019.

Currently out of the existing stock ratings of MIRM, 59 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$82

$22.18 (37.08%)

$77

4 days ago
(07-Aug-2025)

6/20 (30%)

$22.18 (37.08%)

1252

Buy

$81

$21.18 (35.41%)

$76

4 days ago
(07-Aug-2025)

0/13 (0%)

$21.18 (35.41%)

Buy

$72

$12.18 (20.36%)

$66

5 months 14 days ago
(28-Feb-2025)

7/29 (24.14%)

$24.43 (51.36%)

731

Buy

$55

$-4.82 (-8.06%)

$50

5 months 15 days ago
(27-Feb-2025)

8/8 (100%)

$8.02 (17.07%)

330

Buy

$68

$8.18 (13.67%)

$64

8 months 29 days ago
(13-Nov-2024)

4/6 (66.67%)

$24.08 (54.83%)

337

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MIRM (Mirum Pharmaceuticals) average time for price targets to be met?

On average it took 577.75 days on average for the stock forecasts to be realized with a an average price target met ratio 57.64

Which analyst has the current highest performing score on MIRM (Mirum Pharmaceuticals) with a proven track record?

ED ARCE

Which analyst has the most public recommendations on MIRM (Mirum Pharmaceuticals)?

Ed Arce works at HC WAINWRIGHT and has 12 price targets and 8 ratings on MIRM

Which analyst is the currently most bullish on MIRM (Mirum Pharmaceuticals)?

Steven Seedhouse with highest potential upside - $22.18

Which analyst is the currently most reserved on MIRM (Mirum Pharmaceuticals)?

Jessica Fye with lowest potential downside - -$20.82

Mirum Pharmaceuticals in the News

Earnings call transcript: Mirum Pharmaceuticals sees revenue boost in Q2 2025

Mirum Pharmaceuticals Inc. reported its Q2 2025 earnings on August 6, showing a notable improvement in its financial results. The company posted an earnings per share (EPS) of -$0.12, significantly beating the forecasted -$0.33. Revenue came in at $127.78 million, surpassing expectations of $107.36 million, marking a 19.02% surprise. Following the announcement, Mirum’s stock rose...

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FOSTER CITY, Calif., May 09, 2025–(BUSINESS WIRE)–Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on May 9, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 53,230 shares of common stock and 26,585 restricted stock units (“RSUs”) to eight new employees under Mirum’s 2020 Inducement...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?